2-bromo-4-phenoxyaniline | 1335242-91-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2-bromo-4-phenoxyaniline
• 英文别名: 2-Bromo-4-phenoxyaniline
• CAS: 1335242-91-5
• 化学式: C₁₂H₁₀BrNO
• 分子量: 264.121
• InChiKey: IGXIHSSBMKVRFC-UHFFFAOYSA-N

物化性质

• 沸点：
  351.5±32.0 °C(Predicted)
• 密度：
  1.479±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.5
• 重原子数：
  15
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  35.2
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  2-bromo-4-phenoxyaniline 在 劳森试剂 、 吡啶 、 盐酸 、 sodium acetate 、 氯化铵 、 O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate 、 三乙胺 、 sodium hydroxide 、 sodium nitrite 作用下， 以 四氢呋喃 、 甲醇 、 乙醇 、 水 、 N,N-二甲基甲酰胺 为溶剂， 生成 2-(7-bromo-5-phenoxy-1H-indol-2-yl)-4-methyl-1,3-thiazole-5-carboxylic acid
  参考文献：
  名称：

  Structure-based design and biological evaluation of novel 2-(indol-2-yl) thiazole derivatives as xanthine oxidase inhibitors

  摘要：

  Inhibition of xanthine oxidase (XO) has obviously been a central concept for controlling hyperuricemia, which causes serious and painful inflammatory arthritis disease such as gout. We discovered a series of novel 2-(indol-2-yl) thiazole derivatives as XO inhibitors at the level of nanomolar activity. Structure-guided design using molecular modeling program (Accelrys Software program) provided an excellent basis for optimization of 2-(indol-2-yl) thiazole compounds. Structure-activity relationship indicated that hydrophobic alkoxy group (isopropoxy, cyclopentoxy) at 5-position and hydrogen binding acceptor (NO2, CN) at 7-position of indole ring appear as critical functional groups. Among the compounds, 2-(7-nitro-5-isopropoxy- indol-2-yl)-4-methylthiazole-5-carboxylic acid (9m) exhibits the most potent XO inhibitory activity (IC50 value: 5.1 nM) and the excellent uric acid lowering activity in potassium oxonate induced hyperuricemic rat model. (C) 2016 Published by Elsevier Ltd.

  DOI：

  10.1016/j.bmcl.2015.12.055
• 作为产物：
  描述：

  2,6-二溴-4-苯氧基苯胺 在 正丁基锂 作用下， 以 乙醚 、 正己烷 为溶剂， 以50%的产率得到2-bromo-4-phenoxyaniline
  参考文献：
  名称：

  催化不对称Pictet-Spengler型反应合成旋光吲哚[3,4- cd ] [1]苯并ze庚因

  摘要：

  已经引入了一种新的策略，以通过用亚胺代替醛来开发催化不对称的Pictet-Spengler型反应。一系列4-（2-氨基芳基）吲哚在室温下与亚胺平稳地进行手性磷酸催化的不对称Pictet-Spengler型反应，得到结构良好的吲哚[3,4- cd ] [1]苯并ze庚因产量和ee。

  DOI：

  10.1021/ol202361t

文献信息

• Highly Chemoselective Access to 2,2′-Diaminobiaryls via Ni-Catalyzed Protecting-Group-Free Coupling of 2-Haloanilines
  作者：Cheng-Yu Long、Shao-Fei Ni、Min-Hui Su、Xue-Qiang Wang、Weihong Tan

  DOI：10.1021/acscatal.0c03428

  日期：2020.11.20

  development of strategies to access 2,2′-diaminobiaryl derivatives via a transition-metal-catalyzed coupling reaction from protecting-group-free starting materials is a challenging task to accomplish, owing to the easy occurrence of undesired side reactions. The exploitation of Ni-catalyzed direct homocoupling of unprotected 2-haloaniline analogues to produce 2,2′-diaminobiaryls with a readily available

  由于容易发生不希望的副反应，通过过渡金属催化的无保护基起始原料的偶合反应获得2,2'-二氨基联芳基衍生物的策略的开发是一项具有挑战性的任务。已经描述了利用Ni催化的未保护的2-卤代苯胺类似物的直接均偶联以产生具有容易获得且廉价的联吡啶配体的2,2'-二氨基联芳基。该方法具有高度的化学选择性，广泛的底物范围和官能团相容性，从而突显了该方法。机理和计算研究表明，Ni（0），Ni（I），Ni（II）和Ni（III）物种可能参与催化循环。
• Discovery and optimization of 4-anilinoquinazoline derivatives spanning ATP binding site and allosteric site as effective EGFR-C797S inhibitors
  作者：Dou Dou、Jie Wang、Yunjin Qiao、Gulinuer Wumaier、Wenjie Sha、Wenjie Li、Wenyi Mei、Tingyuan Yang、Chen Zhang、Huan He、Caolin Wang、Linna Chu、Baihui Sun、Rongrong Su、Xiangyu Ma、Mengdie Gong、Lijuan Xie、Wenzhe Jiang、Yanyan Diao、Lili Zhu、Zhenjiang Zhao、Zhuo Chen、Yufang Xu、Shengqing Li、Honglin Li

  DOI：10.1016/j.ejmech.2022.114856

  日期：2022.12

  drug target for the treatment of non-small cell lung cancer (NSCLC). However, a tertiary point mutation (C797S) at the ATP binding pocket of the EGFR induces resistance to the third-generation EGFR inhibitors, due to the loss of covalent interaction with Cys797. Here, we designed a series of 4-anilinoquinazoline derivatives that simultaneously occupied the ATP binding pocket and the allosteric site

  表皮生长因子受体 (EGFR) 是治疗非小细胞肺癌 (NSCLC) 的有效药物靶点。然而，由于与 Cys797 的共价相互作用丧失，EGFR 的 ATP 结合口袋处的三级点突变 (C797S) 诱导了对第三代 EGFR 抑制剂的耐药性。在这里，我们设计了一系列同时占据 ATP 结合口袋和变构位点的 4-苯胺基喹唑啉衍生物。新合成的化合物对 EGFR-C797S 抗性突变显示出高效力。其中，化合物14d对 BaF3-EGFR L858R/T790M/C797S (IC 50  = 0.75 μM) 和 BaF3-EGFR 19del/T790M/C797S (IC 50 = 0.09 μM) 细胞。此外，14d在 BaF3-EGFR 19del/T790M/C797S细胞中以剂量依赖的方式对 EGFR 及其下游信号通路产生明显的抑制活性。最后，14d显着抑制 BaF3-EGFR 19del/
• A Sequential Transition Metal and Organocatalytic Approach to the Enantioselective Synthesis of C2-Spiroindoline Systems
  作者：Pooja Sah、Aakash Kumar Gond、Gaurav Saini、Manmohan Kapur

  DOI：10.1021/acs.orglett.3c03716

  日期：2023.12.29

  We report herein an organocatalyzed enantioselective spirocyclization strategy to access valuable C2-spiroindoline scaffolds bearing a quaternary stereocenter via an aza-Michael addition reaction, wherein the acid additive plays the role of dual functionality. The substrates for this key step were put together by an exo-selective, Pd-catalyzed γ-arylation of silyldienol ethers of the corresponding

  我们在此报道了一种有机催化的对映选择性螺环化策略，通过氮杂-迈克尔加成反应获得有价值的带有四元立构中心的C2-螺吲哚啉支架，其中酸添加剂起到双重功能的作用。该关键步骤的底物是通过相应环己烯酮的甲硅烷基二烯醇醚的外选择性、Pd 催化的 γ-芳基化而组合在一起的。低催化剂负载量和慢反应速率之间的紧密结合产生了具有良好对映选择性的C2-螺吲哚啉。
• 1,3-Benzothiazoles as Antimicrobial Agents
  作者：Ivana Defrenza、Alessia Catalano、Alessia Carocci、Antonio Carrieri、Marilena Muraglia、Antonio Rosato、Filomena Corbo、Carlo Franchini

  DOI：10.1002/jhet.2222

  日期：2015.11

  Starting from 2-amino-1,3-mercaptobenzothiazoles recently reported (1a, 1b, 1c, 1d, 1e, 1f, 1g, 1h), a series of the corresponding 2-mercapto-1,3-benzothiazole isosters (2a, 2b, 2c, 2d, 2e, 2f, 2g, 2h) were screened for their in vitro antibacterial and antifungal activities. Results underline that the presence of the mercapto moiety at the 2-position of the heterocyclic nucleus is crucial for activity against bacteria. The biological screening against Candida spp. identified commercial 2f as the most promising compound as antifungal against Candida albicans and tropicalis. Molecular modeling studies supported these results. Then, to enlarge structure-activity relationship (SAR) studies on series 1, newly synthesized compounds (1k, 1l, 1m, 1n, 1o, 1p) were reported. All the compounds belonging to this series and bearing a bulky substituent at the 6-position of the aryl moiety showed high antifungal activity.